FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Sep. 15, 2015--
MEDNAX, Inc. (NYSE:MD), today announced that it is scheduled to make a
presentation on Wednesday, September 16, 2015 at 8:00 a.m. EDT to
investors attending the Bank of America Merrill Lynch Global Healthcare
Conference 2015 in London.
MEDNAX, Inc. is a national medical group comprised of the nation's
leading providers of neonatal, anesthesia, teleradiology, maternal-fetal
and pediatric physician subspecialty services. Physicians and advanced
practitioners practicing as part of MEDNAX are reshaping the delivery of
care within their specialties and subspecialties, using evidence-based
tools, continuous quality initiatives and clinical research to enhance
patient outcomes and provide high-quality, cost-effective care.
Pediatrix Medical Group, a division of MEDNAX, was founded in 1979 and
includes neonatal physicians who provide services at more than 370
neonatal intensive care units, and collaborate with affiliated
maternal-fetal medicine, pediatric cardiology, pediatric critical care
and other physician subspecialists to provide a clinical care continuum.
Pediatrix is also the nation's largest provider of newborn hearing
screens. American Anesthesiology, a division of MEDNAX, was established
in 2007 and includes more than 2,575 anesthesiologists and advanced
practitioners who provide anesthesia care to patients in connection with
surgical and other procedures as well as pain management. MEDNAX,
through its affiliated professional corporations, employs more than
2,750 physicians in 35 states and Puerto Rico. vRad, which MEDNAX
acquired in 2015, provides teleradiology services through a network of
more than 350 radiologists located in all 50 states. In addition to its
national physician network, MEDNAX provides services to medical
providers in over 40 states through two complementary businesses,
consisting of a revenue cycle management company and a consulting
services company. Additional information is available at www.mednax.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150915005302/en/
Source: MEDNAX, Inc.
Charles Lynch, 954-384-0175, Ext. 5692
President, Strategy and Investor Relations